Abstract:Importance: Gallstone pancreatitis (GSP) is the leading cause of acute pancreatitis, accounting for approximately 50% of cases. Without appropriate and timely treatment, patients are at increased risk of disease progression and recurrence. While there is increasing consensus among guidelines for the management of mild GSP, adherence to these guidelines remains poor. In addition, there is minimal evidence to guide clinicians in the treatment of moderately severe and severe pancreatitis. Observations: The management of GSP continues to evolve and is dependent on severity of acute pancreatitis and concomitant biliary diagnoses. Across the spectrum of severity, there is evidence that goal-directed, moderate fluid resuscitation decreases the risk of fluid overload and mortality compared with aggressive resuscitation. Patients with isolated, mild GSP should undergo same-admission cholecystectomy; early cholecystectomy within 48 hours of admission has been supported by several randomized clinical trials. Cholecystectomy should be delayed for patients with severe disease; for severe and moderately severe disease, the optimal timing remains unclear. Preoperative endoscopic retrograde cholangiopancreatography (ERCP) is only useful for patients with suspected cholangitis or biliary obstruction, although the concomitance of these conditions in patients with GSP is rare. Modality of evaluation of the common bile duct to rule out concomitant choledocholithiasis varies and should be tailored to level of concern based on objective measures, such as laboratory results and imaging findings. Among these modalities, intraoperative cholangiography is associated with reduced length of stay and decreased use of ERCP. However, the benefit of routine intraoperative cholangiography remains in question. Conclusions and relevance: Treatment of GSP is dependent on disease severity, which can be difficult to assess. A comprehensive review of clinically relevant evidence and recommendations on GSP severity grading, fluid resuscitation, timing of cholecystectomy, need for ERCP, and evaluation and management of persistent choledocholithiasis can help guide clinicians in diagnosis and management.

Management of Gallstone Disease

The Multifaceted Impact of Gallstones: Understanding Complications and Management Strategies

Management of Gallstone Pancreatitis: A Review

Recent advances in understanding and managing cholesterol gallstones

Managing Gallstone Disease in the Elderly

Gallstones: Prevention, Diagnosis, and Treatment

Metabolic dysfunction-associated gallstone disease: expecting more from critical care manifestations

Factors Influencing Gallstone Formation: A Review of the Literature

Gallstone Disease: Common Questions and Answers

Gallstone pancreatitis: a review

Recent advances, novel targets and treatments for cholelithiasis; a narrative review

Cholesterol cholelithiasis: part of a systemic metabolic disease, prone to primary prevention

Surgical Management of Gallstone Ileus: Approach, Outcome, Case Report, and Literature Review

Management of Bile Duct Stones in the Era of Laparoscopic Cholecystectomy

[Gallstones]

Gallstones in Patients with Chronic Liver Diseases

Hepatolithiasis: Epidemiology, presentation, classification and management of a complex disease

Current practices and future prospects for the management of gallbladder polyps: A topical review

Management of biliary lithiasis in pregnancy – an updated overview

Genetics and treatment of bile duct stones: new approaches

Gastrointestinal microbiome and cholelithiasis: Current status and perspectives